SEC EDGARJUL 91 min read$CNXC

Caldwell Christopher A purchased $21K of CNXC

Caldwell Christopher A (President and CEO) purchased 1,000 shares of Concentrix Corp (CNXC) at $21.25 on 2026-07-08.

Original reporting

SEC EDGAR · Caldwell Christopher A

Published Jul 9, 2026, 10:19 PM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Jul 9, 2026, 10:24 PM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

alphai market briefInsider activity

Primary signal

$CNXC

Bullish

medium confidence

Mentioned

$CNXC

Relevance

4/10

alphai data visualization · based on SEC EDGAR

Decision brief

The 30-second read

$CNXCBullishLow

Why it matters

Traders may treat the CEO purchase as a modest positive sentiment input, but it does not provide new operational, financial, or regulatory information.

Market read

A primary-source insider buy is newly disclosed, but the transaction size suggests limited impact on valuation or near-term trading flows.

What to watch

No 10b5-1 plan is disclosed, but the filing does not provide intent, timing constraints, or whether the purchase is part of a broader pattern.

Relevance 4/10Novelty 5/10Timing: Form 4 filed 2026-07-09, covering a 2026-07-08 insider purchase.

Background

The article is a SEC Form 4 insider transaction disclosure for Concentrix (CNXC) by its President and CEO.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$CNXCBullishMedium confidence

Context

Concentrix CEO bought 1,000 shares on 2026-07-08 at $21.2497, per Form 4 filed 2026-07-09, with no 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless followed by additional disclosures.

Evidence & confidence

Form 4 provides a primary-source transaction, but the disclosed size ($21.25k) is small relative to company scale and the filing includes no 10b5-1 plan, which may increase interpretive attention without changing fundamentals.

Market effects

Sector

Minimal; insider purchase does not materially change the broader IT services/outsourcing read-through.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider open-market buys can be routine liquidity or diversification-related, and the small dollar amount reduces signal strength.

Key entities

issuer
Concentrix Corp
Subject of the Form 4 insider transaction disclosure.
insider
Caldwell Christopher A
President and CEO who purchased 1,000 shares open-market at $21.2497 on 2026-07-08.

Read at source ← All news

AUG 28

$ARMKMedAI 8/10

A Look Back at Business Process Outsourcing & Consulting Stocks’ Q2 Earnings: Aramark (NYSE:ARMK) Vs The Rest Of The Pack

Huron (HURN) reported fastest revenue growth and highest guidance raise, with stock up 28.9%. Concentrix (CNXC) had weakest Q2, missing EPS and revenue guidance, but stock up 9.7%. Genpact (G) reported mixed results, with stock up 2.2%. TaskUs (TASK) beat revenue expectations, stock up 22.9%.

finance.yahoo.com3 min

AUG 10

$METAMed

Meta cuts Wipro outsourcing work by at least 25%

Meta reduced IT outsourcing work with Wipro by at least 25%, cutting Wipro’s expected annual revenue from the account to about $75 million from roughly $100 million in fiscal 2026, according to Investing.com citing two sources. The change follows Meta’s AI-driven closure of its digital marketing division, ending related vendor work. Concentrix, Teleperformance, and Accenture were also affected, per Mint.

news.outsourceaccelerator.com6 min

JUL 23

$CNXCHighAI 9/10

Why Concentrix (CNXC) Shares Are Getting Obliterated Today

Concentrix (CNXC) shares fell about 8% after the company reported Q2 fiscal 2026 results and cut guidance. Adjusted EPS was $2.63, below estimates. Q3 EPS guidance was $2.65–$2.77 versus $3.08 consensus, and full-year EPS was lowered to $10.83–$11.18 from $11.48–$12.07, citing offshoring, demand variability, and $175 million restructuring charges.

financialcontent.com4 min

JUL 14

$CNXCMedAI 8/10

Concentrix (CNXC) Securities Fraud Investigation - Levi & Korsinsky

Levi & Korsinsky says Concentrix (NASDAQ: CNXC) shareholders lost about 20% after the company reported Q2 2026 results below consensus on revenue and EPS and cut full-year 2026 guidance. Revenue guidance was lowered to $9.93-$10.03 billion from $10.11 billion midpoint, and non-GAAP EPS to $10.83-$11.18 from $11.48-$12.07, citing off-shoring headwinds.

prnewswire.com3 min

JUL 7

$CNXCMed

Concentrix Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of Concentrix (CNXC)

Levi & Korsinsky says it is investigating Concentrix (NASDAQ: CNXC) over potential securities-law issues tied to Q2 2026 results and revised guidance. The firm alleges prior statements implied at least $10.035B revenue and $1.24B non-GAAP operating income, but updated outlook tops $10.025B and $1.23B; CNXC shares fell over 20% on the news.